Table 2.
Total | P-Value | Men | Women | P-Value | ||
---|---|---|---|---|---|---|
Psychotic presentations | SC | 129 (79.6%) | <0.001 | 99 (79.8%) | 30 (78.9%) | 1.000 |
MJ | 168 (57.5%) | 121 (61.1%) | 47 (50.0%) | 0.077 | ||
Control | 235 (44.4%) | 175 (46.4%) | 60 (39.5%) | 0.149 | ||
Haldol equivalent dose of antipsychotic medications (mean, SD) | SC | 10.72 (7.77) | <0.001 | 10.25 (7.47) | 11.96 (8.67) | 0.264 |
MJ | 5.15 (6.87) | 5.80 (7.13) | 3.79 (6.11) | 0.019 | ||
Control | 5.27 (7.08) | 5.47 (7.25) | 4.77 (6.65) | 0.305 | ||
Agitation (PRN+) | SC | 87 (53.7%) | <0.001 | 59 (47.6%) | 28 (73.7%) | 0.005 |
MJ | 116 (39.7%) | 82 (41.4%) | 34 (36.2%) | 0.443 | ||
Control | 156 (29.5%) | 118 (31.3%) | 38 (25.0%) | 0.171 | ||
Length of hospital stay (days) (mean, SD) | SC | 15.19 (11.31) | <0.001 | 14.23 (10.91) | 18.43 (12.14) | 0.047 |
MJ | 10.73 (8.56) | 10.91 (9.27) | 10.35 (6.85) | 0.604 | ||
Control | 12.40 (12.11) | 12.67 (12.83) | 11.70 (10.13) | 0.405 |